Prenatal exposure to persistent organic pollutants and markers of obesity and cardiometabolic risk in Spanish adolescents.
Adolescent
Adult
Biomarkers
Cardiovascular Diseases
/ epidemiology
Child
Child, Preschool
Cohort Studies
Environmental Pollutants
/ toxicity
Female
Humans
Longitudinal Studies
Obesity
/ epidemiology
Persistent Organic Pollutants
Pregnancy
Prenatal Exposure Delayed Effects
/ epidemiology
Spain
/ epidemiology
Cardiometabolic syndrome
Dichlorodiphenyltrichloroethane (p,p’-DDT)
Endocrine disruptors
Hexachlorobenzene (HCB)
Persistent organic pollutants (POPs)
Polychlorinated biphenyls (PCBs)
Journal
Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
16
11
2020
revised:
10
02
2021
accepted:
15
02
2021
pubmed:
13
3
2021
medline:
27
4
2021
entrez:
12
3
2021
Statut:
ppublish
Résumé
Prenatal exposure to persistent organic pollutants (POPs) has been linked to cardiometabolic (CM) risk factors in childhood, but there are no studies evaluating the persistence of these associations into adolescence, a period of relevant changes in endocrine-dependent organ systems and rapid increases in lean and fat mass. We examined the associations of prenatal POP exposures with body mass index (BMI) from age 4 to 18 years, and with other CM risk markers in adolescence. We analysed 379 children from the Spanish INMA-Menorca birth cohort study with measured cord blood POP concentrations. We calculated BMI z-scores at ages 4, 6, 11, 14 and 18 years using the WHO growth reference. Body fat % was measured at 11 and 18 years and waist-to-height ratio (WHtR) and blood pressure (BP) at 11, 14 and 18 years. We measured CM biomarkers in fasting blood collected at age 14 years and calculated a CM-risk score as the sum of the sex-, and age-specific z-scores for waist circumference, mean arterial BP, homeostatic model assessment of insulin resistance, fasting blood triglycerides, and high-density lipoprotein cholesterol (HDL-C) (n = 217). Generalised estimating equations and multivariate linear regression models assessed the associations with repeated and single time-point measures, respectively. Hexachlorobenzene (HCB) exposure in the third tertile, compared to the first tertile, was associated with higher BMI (β = 0.24; 95% CI: 0.01, 0.47) and WHtR z-score (β = 0.27; 95% CI: 0.04, 0.51). A continuous increase in HCB was associated with an elevated body fat % (β per 10-fold increase = 4.21; 95% CI: 0.51, 7.92), systolic BP (β = 0.32; 95% CI: 0.02, 0.64) and diastolic BP z-score (β = 0.32; 95% CI: 0.02, 0.62) across all ages, and with higher CM-risk score (β = 1.59; 95% CI: 0.02, 3.18) and lipid biomarkers (total cholesterol, triglycerides and low-density lipoprotein cholesterol (LDL-C)) at 14 years. Dichlorodiphenyltrichloroethane (p,p'-DDT) exposure was non-monotonically associated with BMI and systolic BP. p,p'-DDE and Σ-polychlorinated biphenyls (PCBs) (sum of congeners 118, 138, 153, 180) were not associated with adiposity or BP. p,p'-DDT exposure was associated with an increased CM-risk score, and ΣPCBs concentrations with LDL-C in all adolescents and with total cholesterol only in girls (p-sex interaction = 0.05). This first longitudinal study from 4 to 18 years suggests that the previously reported POP associations with child BMI persist later in adolescence and that prenatal POP exposures are associated with major risk factors for adult CM syndrome.
Sections du résumé
BACKGROUND
Prenatal exposure to persistent organic pollutants (POPs) has been linked to cardiometabolic (CM) risk factors in childhood, but there are no studies evaluating the persistence of these associations into adolescence, a period of relevant changes in endocrine-dependent organ systems and rapid increases in lean and fat mass. We examined the associations of prenatal POP exposures with body mass index (BMI) from age 4 to 18 years, and with other CM risk markers in adolescence.
METHODS
We analysed 379 children from the Spanish INMA-Menorca birth cohort study with measured cord blood POP concentrations. We calculated BMI z-scores at ages 4, 6, 11, 14 and 18 years using the WHO growth reference. Body fat % was measured at 11 and 18 years and waist-to-height ratio (WHtR) and blood pressure (BP) at 11, 14 and 18 years. We measured CM biomarkers in fasting blood collected at age 14 years and calculated a CM-risk score as the sum of the sex-, and age-specific z-scores for waist circumference, mean arterial BP, homeostatic model assessment of insulin resistance, fasting blood triglycerides, and high-density lipoprotein cholesterol (HDL-C) (n = 217). Generalised estimating equations and multivariate linear regression models assessed the associations with repeated and single time-point measures, respectively.
RESULTS
Hexachlorobenzene (HCB) exposure in the third tertile, compared to the first tertile, was associated with higher BMI (β = 0.24; 95% CI: 0.01, 0.47) and WHtR z-score (β = 0.27; 95% CI: 0.04, 0.51). A continuous increase in HCB was associated with an elevated body fat % (β per 10-fold increase = 4.21; 95% CI: 0.51, 7.92), systolic BP (β = 0.32; 95% CI: 0.02, 0.64) and diastolic BP z-score (β = 0.32; 95% CI: 0.02, 0.62) across all ages, and with higher CM-risk score (β = 1.59; 95% CI: 0.02, 3.18) and lipid biomarkers (total cholesterol, triglycerides and low-density lipoprotein cholesterol (LDL-C)) at 14 years. Dichlorodiphenyltrichloroethane (p,p'-DDT) exposure was non-monotonically associated with BMI and systolic BP. p,p'-DDE and Σ-polychlorinated biphenyls (PCBs) (sum of congeners 118, 138, 153, 180) were not associated with adiposity or BP. p,p'-DDT exposure was associated with an increased CM-risk score, and ΣPCBs concentrations with LDL-C in all adolescents and with total cholesterol only in girls (p-sex interaction = 0.05).
CONCLUSION
This first longitudinal study from 4 to 18 years suggests that the previously reported POP associations with child BMI persist later in adolescence and that prenatal POP exposures are associated with major risk factors for adult CM syndrome.
Identifiants
pubmed: 33711537
pii: S0160-4120(21)00094-5
doi: 10.1016/j.envint.2021.106469
pmc: PMC7960637
pii:
doi:
Substances chimiques
Biomarkers
0
Environmental Pollutants
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106469Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES023515
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES029328
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Environ Int. 2008 May;34(4):546-61
pubmed: 18054079
Int J Obes (Lond). 2014 Jul;38(7):919-25
pubmed: 24718355
Environ Health. 2015 Jun 20;14:54
pubmed: 26092037
Diabetes Metab J. 2011 Jun;35(3):207-15
pubmed: 21785739
Hypertension. 2014 Apr;63(4):683-91
pubmed: 24379180
Environ Res. 2015 Apr;138:217-23
pubmed: 25725302
Arch Pediatr. 2009 Jan;16(1):47-53
pubmed: 19036567
Environ Health Perspect. 2009 Mar;117(3):417-25
pubmed: 19337517
Environ Sci Technol. 2006 Mar 1;40(5):1420-6
pubmed: 16568751
Matern Child Nutr. 2018 Apr;14(2):e12561
pubmed: 29171150
Obesity (Silver Spring). 2014 Feb;22(2):488-96
pubmed: 23963708
Pediatr Res. 2002 Dec;52(6):863-7
pubmed: 12438662
Pediatrics. 2005 Apr;115(4):e500-3
pubmed: 15741351
Environ Health Perspect. 2015 Oct;123(10):1030-7
pubmed: 25956007
J Environ Monit. 2007 Jun;9(6):523-9
pubmed: 17554423
Nutrients. 2019 Dec 23;12(1):
pubmed: 31877943
Chemosphere. 2006 Aug;64(9):1507-13
pubmed: 16466768
Environ Health Perspect. 2017 Sep 18;125(9):096002
pubmed: 28934091
BMJ Open. 2016 Aug 11;6(8):e011626
pubmed: 27515754
Environ Health Perspect. 2015 Jul;123(7):730-6
pubmed: 25742056
Circulation. 2008 Jun 24;117(25):3171-80
pubmed: 18559702
Environ Health Perspect. 2016 Nov;124(11):1722-1727
pubmed: 27325568
Environ Pollut. 2018 Feb;233:855-861
pubmed: 29248762
Am J Clin Nutr. 2002 Nov;76(5):991-9
pubmed: 12399270
Environ Res. 2010 Apr;110(3):244-50
pubmed: 20122686
Environ Health Perspect. 2011 Mar;119(3):377-83
pubmed: 21156398
Environ Health Perspect. 2011 Mar;119(3):319-25
pubmed: 21362590
Am J Epidemiol. 2014 Jun 1;179(11):1312-22
pubmed: 24722999
Environ Health Perspect. 2015 Oct;123(10):1015-21
pubmed: 25910281
Toxicol Lett. 2008 Dec 15;183(1-3):65-71
pubmed: 18992306
Endocrinology. 2015 Oct;156(10):3416-21
pubmed: 26241070
J Hypertens. 2013 Aug;31(8):1547-53
pubmed: 23743808
Reprod Toxicol. 2017 Mar;68:3-33
pubmed: 27760374
Acta Paediatr. 2008 Oct;97(10):1465-9
pubmed: 18665907
J Pediatr. 2011 Oct;159(4):584-90
pubmed: 21514597
Environ Res. 2014 Feb;129:27-31
pubmed: 24528999
Chemosphere. 2005 Aug;60(7):898-906
pubmed: 15992596
Environ Sci Pollut Res Int. 2016 Jul;23(14):14284-93
pubmed: 27055888
PLoS One. 2015 Jun 30;10(6):e0131443
pubmed: 26125556
Environ Int. 2018 Apr;113:122-132
pubmed: 29421401
Environ Health Perspect. 2009 Jan;117(1):122-6
pubmed: 19165398
Environ Res. 2013 Apr;122:65-73
pubmed: 23375553
Environ Int. 2015 Jan;74:23-31
pubmed: 25314142
Xenobiotica. 1998 May;28(5):479-92
pubmed: 9622850
Environ Health Perspect. 2013 Sep;121(9):1103-9
pubmed: 23799652
PLoS One. 2014 Jul 30;9(7):e103337
pubmed: 25076055
Environ Health Perspect. 2010 Apr;118(4):465-71
pubmed: 20064776
Environ Health. 2018 Jan 18;17(1):9
pubmed: 29347948
Epidemiology. 2009 Jul;20(4):496-9
pubmed: 19525686
Chemosphere. 2011 Jan;82(1):114-20
pubmed: 20965545
Chemosphere. 2018 Mar;195:576-584
pubmed: 29277037
Endocr Rev. 2013 Jun;34(3):309-38
pubmed: 23460719
Sci Rep. 2016 Jul 20;6:29971
pubmed: 27436227
Environ Res. 2015 Oct;142:407-13
pubmed: 26232659
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Nature. 2020 Jun;582(7810):73-77
pubmed: 32494083
J Pediatr Endocrinol Metab. 2007 Feb;20(2):187-95
pubmed: 17396435
Int J Environ Res Public Health. 2016 Feb 29;13(3):
pubmed: 26938545
Environ Res. 2012 Feb;113:58-62
pubmed: 22244494
Arch Dis Child. 2010 Aug;95(8):612-7
pubmed: 20522467
Bull World Health Organ. 2007 Sep;85(9):660-7
pubmed: 18026621
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Am J Clin Nutr. 2014 Jan;99(1):5-13
pubmed: 24153349
Endocrinology. 2006 Jun;147(6 Suppl):S50-5
pubmed: 16690801
N Engl J Med. 2011 Nov 17;365(20):1876-85
pubmed: 22087679
Environ Res. 2014 Jul;132:24-32
pubmed: 24742724
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
Am J Epidemiol. 2010 Aug 15;172(4):478-87
pubmed: 20616200
Korean J Anesthesiol. 2019 Dec;72(6):558-569
pubmed: 31304696
Environ Health Perspect. 2011 Feb;119(2):272-8
pubmed: 20923745
Environ Health Perspect. 2012 Mar;120(3):451-7
pubmed: 22027556
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Obes Rev. 2012 Mar;13(3):275-86
pubmed: 22106927
N Engl J Med. 2010 Feb 11;362(6):485-93
pubmed: 20147714
Cardiovasc Diabetol. 2008 Jun 05;7:17
pubmed: 18534019
Int J Epidemiol. 2012 Aug;41(4):930-40
pubmed: 21471022
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Reprod Toxicol. 2017 Mar;68:145-153
pubmed: 27496715
Hypertension. 2018 Jun;71(6):1258-1268
pubmed: 29712742
Environ Res. 2017 Nov;159:606-612
pubmed: 28917205
PLoS One. 2020 Jun 23;15(6):e0232749
pubmed: 32574162